查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498369

全球糖組學/糖生物學市場評估：依產品類型、應用、最終用戶、地區、機會、預測（2017-2031）

Glycomics/Glycobiology Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5個工作天內

價格

全球糖組學/糖生物學市場規模預計將從 2023 年的 19.2 億美元增至 2031 年的 58.5 億美元，預計 2024 年至 2031 年的複合年增長率為 14.93%。該市場近年來呈現顯著成長，預計未來將保持強勁的擴張速度。

隨著研究人員不斷探索聚醣的複雜性及其與其他生物分子的相互作用，異常的聚醣結構和糖基化模式在自體免疫疾病、糖尿病、癌症和其他疾病中變得越來越普遍，並且越來越多地與各種疾病有關。因此，糖組學學術領域旨在闡明聚醣的結構、功能以及對健康和疾病的影響，並為聚醣識別、管理和藥物發現提供可能性。許多相互關聯的變數正在推動全球糖組學市場的成長軌跡。糖組學作為診斷和治療與異常糖基化模式相關的疾病（例如糖尿病和癌症）的潛在手段而受到廣泛關注。這些尖端工具使研究人員能夠進一步深入研究聚醣的複雜性及其在健康和疾病中的功能意義。

向個人化醫療的範式轉變進一步強調了糖組學在確定醫療保健方向方面的重要性。透過提供針對客製化治療計畫的見解，聚醣分析有可能顯著提高醫療介入的有效性和精確度。以患者為中心的醫學方法表明，糖組學對於邁向以患者為中心的治療選擇有多麼重要。快速發展的生物製藥產業正在認識到聚醣分析對於生物藥物發現的重要性。例如，2024 年 1 月 30 日，基於原位鄰近連接分析的創新解決方案的領導者 Navinci Diagnostics AB Corp 與創新蛋白質組學和聚醣研究解決方案的先驅 Vector Laboratories 簽署了一項協議。此次合作旨在創建一種創新的生物標記發現技術，首次識別組織樣本中的蛋白質糖基化。

不斷增長的醫療支出推動市場

全球醫療保健支出的穩定成長正在為全球糖組學市場帶來巨大繁榮。公共和商業組織都為醫學研究和開發項目提供了大量資金，這推動了糖組學等領域的投資。對聚醣在各種生物過程中的重要功能及其對人類健康影響的瞭解的加深反映在資金的增加上。人們對理解和治療複雜疾病（其中許多涉及聚醣相關過程）的日益關注正在增加醫療保健支出。因此，對糖組學研究、診斷和治療的需求預計在未來幾年將顯著增加。

全球醫療支出預計將持續增加，糖組學市場也有望大幅成長。糖組學的創新和進步預計將受到醫學研發投資增加的推動。研究中心、製藥公司和學術機構之間的合作有望推動這一領域的發展。這些策略聯盟促進跨學科合作、資源共享和知識交流，創造有利於突破性發現和基於聚醣的療法的創造的氛圍。隨著個人化醫療的形成，對聚醣研究和診斷的需求預計將迅速增加。聚醣分析在提供對疾病和治療反應的個人化見解方面具有巨大潛力，特別強調根據每個患者獨特的生物學特徵定製藥物治療，考慮到這種情況的可能性很大。因此，Glycomics 有潛力為以患者為中心的醫療解決方案的開發做出重大貢獻並刺激進一步成長。

本報告研究和分析了全球糖組學/糖生物學市場，提供市場規模和預測、市場動態以及主要參與者的現狀和前景。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章全球糖組學/糖生物學市場展望（2017-2031 年）

  • 市場規模與預測
    • 金額
    • 數量
  • 依產品類型
    • □
    • 套件
    • 試劑、化學品
    • 碳水化合物
    • 設備
  • 依用途
    • 藥物發現與開發
    • 診斷
    • 其他
  • 依最終用戶
    • 學術研究所
    • 製藥公司、生技公司
    • 臨床實驗室
    • 開發合約組織
  • 依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 5 章全球糖組學/糖生物學市場展望：依地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 依產品類型
    • 依用途
    • 依最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 6 章市場地圖（2023 年）

  • 依產品類型
  • 依用途
  • 依最終用戶
  • 依地區

第七章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第 9 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第十章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家市場公司）
  • 專利分析（如果適用）

第11章價格分析

第 12 章案例研究

第十三章主要公司展望

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Waters Corporation
  • New England Biolabs France SASU
  • Bruker Corporation
  • Takara Bio USA, Inc.
  • Danaher Corporation
  • Bio-Techne Corporation
  • Shimadzu Corporation

第 14 章策略建議

第十五章關於我們公司，免責聲明

Product Code: MX11493

Global glycomics/glycobiology market is projected to witness a CAGR of 14.93% during the forecast period 2024-2031F, growing from USD 1.92 billion in 2023 to USD 5.85 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Glycans' abnormal structures or glycosylation patterns are increasingly being connected to various diseases, like autoimmune disorders, diabetes, and cancer, as researchers continue to explore the intricacies of glycans and their interactions with other biomolecules. As a result, the discipline of glycomics aims to clarify glycan structures, functions, and effects on health and illness, signaling possible advances in identifying, managing, and creating new drugs. Numerous interconnected variables are driving the worldwide glycomics market's growth trajectory. Glycomomics has gained significant attention as a potential means of diagnosing and treating diseases, including diabetes and cancer, linked to aberrant glycosylation patterns. Due to these state-of-the-art tools, researchers may delve further into the complexity of glycans and their functional significance in both health and disease.

The importance of glycomics in influencing the direction of healthcare is further highlighted by the paradigm shift towards personalized medicine. Glycan profiling has the potential to significantly increase the effectiveness and accuracy of medical interventions by offering tailored insights into customized treatment plans. The patient-centered approach to healthcare emphasizes how important glycomics is to progress towards patient-centered therapeutic options. The rapidly growing biopharmaceutical sector is realizing how important glycan analysis is to creating biologics. For instance, on January 30, 2024, Navinci Diagnostics AB Corp, the leader in breakthrough in situ proximity ligation assay-based solutions, and Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, announced the signing of an agreement. The collaboration aims to create innovative biomarker discovery techniques that will identify protein glycosylation in tissue samples for the first time.

Increasing Expenditure on Healthcare to Propel the Market

The steady rise in healthcare spending across the globe is providing a significant boom to the global glycomics market. Both public and commercial organizations are contributing more money to healthcare research and development projects, which drives investments in fields such as glycomics. An improved understanding of glycans' critical function in different biological processes and their consequences for human health is reflected in increased financial commitment. More emphasis is being given to comprehending and treating complicated diseases, many of which involve glycan-related processes, resulting from boosted healthcare spending. Thus, it is anticipated that in the upcoming years, there will be a huge need for glycomics research, diagnostics, and treatments.

The worldwide healthcare expenditure is expected to continue rising, and the glycomics market is expected to rise significantly. Innovation and advances in glycomics are expected to be fueled by the increased investment in healthcare research and development. Research centers, pharmaceutical corporations, and academic institutions working together are expected to propel the sector forward. These strategic alliances promote interdisciplinary cooperation, resource sharing, and exchange of knowledge, which creates an atmosphere that is favorable for ground-breaking discoveries and creation of glycan-based therapeutics. The demand for glycomics research and diagnostics is predicted to rise sharply as personalized medicine takes shape. Glycan profiling has great potential in offering individualized insights into diseases and treatment responses, particularly considering the growing emphasis on customizing medical therapies to each patient's unique biological profile. Therefore, glycomics has the potential to significantly contribute to the development of patient-centric healthcare solutions and spur additional growth.

The pharmaceutical industry is paying more attention to the medicinal potential of glycans in addition to research and diagnostics. With tremendous potential for treating numerous diseases, the field of glycan-based therapy development is a rapidly expanding drug discovery and development area. Improved patient outcomes, addressing unmet medical needs, and collaborative initiatives between academia and industry are anticipated to accelerate the translation of glycomics research into clinically relevant medicines. Due to the rising healthcare costs, more money is being spent on research and development, and the concerted efforts of players in the government, business, and academic sectors, the worldwide glycomics market is expected to rise significantly. For instance, Thermo Fisher Scientific Inc. and TransMIT GmbH Center for Mass Spectrometric Developments announced a co-marketing agreement in June 2022 to further promote the use of mass spectrometry imaging (MSI) platforms for spatial multi-omics applications in clinical and pharmaceutical laboratories.

Expanding Biopharmaceutical Research to Expand the Market

Over the past few decades, biopharmaceutical research has rapidly evolved, with a primary focus on creating novel medicines for a range of diseases and disorders. Glycomics is one of the fields to study that has attracted a lot of interest lately. Glycans are essential to many biological functions. Growth in the global glycomics market is significant as biopharmaceutical research is growing. Biopharmaceutical research is at the forefront of medical discovery and development, especially in the areas of immunology, infectious illnesses, and oncology. Glycomics is becoming more important to researchers and pharmaceutical businesses as a means of comprehending causes of illnesses and developing personalized treatments.

Glycomics research in the biopharmaceutical industry is growing due to several variables. Advances in personalized medicine necessitate a deeper comprehension of the distinct biomarkers, such as glycans, exclusive to each patient. Glycomics can customize treatments according to a patient's unique glycan profile, increasing therapeutic efficacy and reducing adverse effects. Cancer treatment has been transformed by immunotherapies and glycomics, which is essential for comprehending the glycan-based interactions that cancer cells have with the immune system. Glycan-targeted immunotherapies are being actively investigated by researchers to enhance the efficacy of cancer treatment. Since glycans are important in many infections, they are interesting targets for vaccine development.

Glycan-based vaccines are being funded by biopharmaceutical companies to fight infectious diseases such as COVID-19, HIV, and influenza. Glycans are becoming more valuable as disease indicators. The discovery of glycan biomarkers that can help with early illness detection, disease monitoring, and therapy response assessment is being driven by biopharmaceutical research. The market for glycomics goods and services has grown significantly due to glycomics' growing significance in biopharmaceutical research. Technologies, including mass spectrometry, liquid chromatography, and glycan analysis kits, are included in the global glycomics market. It includes services such as glycoprotein characterization and glycan profiling. Innovation in glycomics research is being fostered by partnerships among research centers, pharmaceutical corporations, and university institutions. These collaborations aim to hasten the advancement of glycan-based treatments and diagnostics.

For instance, Bruker Corporation reported advances in glycoproteomics, immunopeptidomics, and other 4D proteomics workflows enabled by Collision Cross Section (CCS) on March 11, 2024. Rapid advancements in glycomics, peptidomics, and deep, at-scale proteomics research solutions from Bruker Corporation enhance its other industry-leading, high-performance life science technologies for the post-genomic era. When combined, they provide vital insights into disease biology and biomarkers for the development of next-generation molecular diagnostics and pharmaceuticals, as well as post-genomic molecular and cell biology research

Increasing Dominance of the Drug Discovery Segment

Developing novel medications is becoming more necessary as chronic disease burdens rise. Glycans are essential for biological functions such as cell-to-cell contact, making them crucial for creating new drugs. Consequently, glycan chains are changed to create medications. For instance, hyaluronan, a naturally occurring glycosaminoglycan disaccharide unit, has several medicinal uses. It is crucial for treating osteoarthritis and is used in wound care following surgery. Studying glycans at the nanoscale can help with the development of vaccinations, medication delivery strategies, and biomolecular therapies for viruses and infectious disorders. Using glycoprotein expression systems and genetic engineering methods, glycan-based self-adjuvanted vaccines can be developed to enhance immunogenicity and vaccine response. Glycobiology is, therefore, crucial to creating vaccines, which fuels the market's expansion. The Mizutani Foundation for Glycoscience received 119 proposals for research grants from 28 different countries in February 2022. Following a thorough assessment of the projects' potential, scientific and social quality, and viability, the Foundation chose to fund 14 projects with grants totaling about USD 0.51 million. Therefore, Grants and approvals are anticipated to stimulate glycobiology research and development, accelerating the segment's growth.

North America to Dominate the Glycomics/Glycobiology Market

Opportunities for North America are anticipated to increase due to the growing prevalence of chronic diseases in the United States, government funding programs, and increased research and development. Cold Spring Harbour Laboratory Press (CSHL Press), a publisher of scientific books, journals, and electronic media, launched a new initiative in September 2022 to give access to the rapidly expanding subject of glycobiology in the United States. Support for the grant for CSHL Press comes from InterVenn Biosciences, a clinical technology business using glycoproteomics to change the face of healthcare. It suggests glycobiology is receiving more attention, which is anticipated to drive market expansion in the United States in the upcoming years.

One of the developers of cutting-edge proteome and glycobiology solutions, Vector Laboratories, Inc. launched a new location in Newark, California, in March 2022. These immunofluorescence (IF) kits are fully integrated to detect glycan expression in tissue slices and allow the profiling and characterization of complex glycans in biological systems. Glycan research is becoming more popular as more academics are interested in studying glycobiology because of its possible influence on significant areas of medical research, such as oncology. Therefore, the market under study is anticipated to grow rapidly throughout the projected period due to the abovementioned factors.

Future Market Scenario (2024 - 2031F)

One of the main factors contributing to the anticipated growth of the glycomics/glycobiology market is the increasing prevalence of chronic disorders such as cancer and diabetes and the increasing popularity of personalized medicine approaches. A rising population and sedentary lifestyles are expected to propel the market growth in the forecast period. Given that technology is advancing, we can expect cutting-edge technology. Players in the market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, using unbiased lipidomics, glycomics, and metabolomics tissue imaging in conjunction with HiPLEX-IHC peptide code antibody probes from AmberGen, Bruker Corporation introduced a unique MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex in April 2022.

Key Players Landscape and Outlook

Several companies are expanding their business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed products, to help researchers and to increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

As part of a larger investment, by 2025, Merck KGaA will invest over USD 320.93 million (EUR 300 million) in a new Life Science Research Center at its headquarters in Darmstadt in 2023. The facility's research efforts will be concentrated on finding solutions of mRNA applications, antibody synthesis, and other biotechnological products. Establishing operations in 2027 will further strengthen Merck's commitment to scientific progress.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Glycomics/Glycobiology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Enzymes
      • 4.2.1.1. Glycosidases
      • 4.2.1.2. Transferases
      • 4.2.1.3. Others
    • 4.2.2. Kits
      • 4.2.2.1. Glycan Releasing Kits
      • 4.2.2.2. Glycan Labelling Kits
      • 4.2.2.3. Glycan Purification Kits
      • 4.2.2.4. Others
    • 4.2.3. Reagents and Chemicals
    • 4.2.4. Carbohydrates
      • 4.2.4.1. Oligosaccharides
      • 4.2.4.2. Monosaccharides
    • 4.2.5. Instruments
      • 4.2.5.1. Mass Spectrometry Instruments
      • 4.2.5.2. Chromatography Instruments
      • 4.2.5.3. Arrays
      • 4.2.5.4. Others
  • 4.3. By Application
    • 4.3.1. Drug Discovery and Development
    • 4.3.2. Diagnostics
    • 4.3.3. Others
  • 4.4. By End-user
    • 4.4.1. Academic and Research Institutes
    • 4.4.2. Pharmaceutical and Biotechnology Companies
    • 4.4.3. Clinical Laboratories
    • 4.4.4. Contract Research Organisations
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Glycomics/Glycobiology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Enzymes
        • 5.1.2.1.1. Glycosidases
        • 5.1.2.1.2. Transferases
        • 5.1.2.1.3. Others
      • 5.1.2.2. Kits
        • 5.1.2.2.1. Glycan Releasing Kits
        • 5.1.2.2.2. Glycan Labelling Kits
        • 5.1.2.2.3. Glycan Purification Kits
        • 5.1.2.2.4. Others
      • 5.1.2.3. Reagents and Chemicals
      • 5.1.2.4. Carbohydrates
        • 5.1.2.4.1. Oligosaccharides
        • 5.1.2.4.2. Monosaccharides
      • 5.1.2.5. Instruments
        • 5.1.2.5.1. Mass Spectrometry Instruments
        • 5.1.2.5.2. Chromatography Instruments
        • 5.1.2.5.3. Arrays
        • 5.1.2.5.4. Others
    • 5.1.3. By Application
      • 5.1.3.1. Drug Discovery and Development
      • 5.1.3.2. Diagnostics
      • 5.1.3.3. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Academic and Research Institutes
      • 5.1.4.2. Pharmaceutical and Biotechnology Companies
      • 5.1.4.3. Clinical Laboratories
      • 5.1.4.4. Contract Research Organisations
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
        • 5.1.5.1.1. By Value
        • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product Type
        • 5.1.5.2.1. Enzymes
          • 5.1.5.2.1.1. Glycosidases
          • 5.1.5.2.1.2. Transferases
          • 5.1.5.2.1.3. Others
        • 5.1.5.2.2. Kits
          • 5.1.5.2.2.1. Glycan Releasing Kits
          • 5.1.5.2.2.2. Glycan Labelling Kits
          • 5.1.5.2.2.3. Glycan Purification Kits
          • 5.1.5.2.2.4. Others
        • 5.1.5.2.3. Reagents and Chemicals
        • 5.1.5.2.4. Carbohydrates
          • 5.1.5.2.4.1. Oligosaccharides
          • 5.1.5.2.4.2. Monosaccharides
        • 5.1.5.2.5. Instruments
          • 5.1.5.2.5.1. Mass Spectrometry Instruments
          • 5.1.5.2.5.2. Chromatography Instruments
          • 5.1.5.2.5.3. Arrays
          • 5.1.5.2.5.4. Others
      • 5.1.5.3. By Application
        • 5.1.5.3.1. Drug Discovery and Development
        • 5.1.5.3.2. Diagnostics
        • 5.1.5.3.3. Others
      • 5.1.5.4. By End-user
        • 5.1.5.4.1. Academic and Research Institutes
        • 5.1.5.4.2. Pharmaceutical and Biotechnology Companies
        • 5.1.5.4.3. Clinical Laboratories
        • 5.1.5.4.4. Contract Research Organisations
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Merck KGaA
  • 13.3. Agilent Technologies, Inc.
  • 13.4. Waters Corporation
  • 13.5. New England Biolabs France SASU
  • 13.6. Bruker Corporation
  • 13.7. Takara Bio USA, Inc.
  • 13.8. Danaher Corporation
  • 13.9. Bio-Techne Corporation
  • 13.10. Shimadzu Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Glycomics/Glycobiology Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 16. United States Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 21. Canada Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Mexico Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Europe Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 37. Germany Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 42. France Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 43. France Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Italy Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 52. United Kingdom Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 57. Russia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 62. Netherlands Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Spain Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Turkey Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Poland Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 82. South America Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 88. Brazil Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Argentina Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 101. India Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 104. India Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 105. India Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 109. China Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 110. China Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 114. Japan Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 119. Australia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 124. Vietnam Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 129. South Korea Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Indonesia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 139. Philippines Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 144. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 150. Saudi Arabia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 155. UAE Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 160. South Africa Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023